Patents by Inventor Mark Dornan

Mark Dornan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12514939
    Abstract: Stabilized radiopharmaceutical formulations or dosage forms comprising radiolabeled conjugates of formula RC-L-TM are disclosed. Methods of making and using stabilized radiopharmaceutical formulations or dosage forms comprising the radiolabeled conjugates are also disclosed, including the preparation and stabilization of targeted radiodiagnostic and radiotherapeutic compounds comprising the radiolabeled conjugate.
    Type: Grant
    Filed: February 18, 2025
    Date of Patent: January 6, 2026
    Assignee: ALPHA-9 ONCOLOGY, INC.
    Inventors: Alison Fleming, Megan Bumgarner, Thomas Kostelnik, Imma Carbo-Bague, Julie Rousseau, Chengcheng Zhang, Kaveh Matinkhoo, Jutta Wanner, Mark Dornan
  • Publication number: 20250127940
    Abstract: Radiopharmaceutical compositions with extended shelf life are provided, including radiopharmaceutical agents that include one or aryl-halide moieties and formulated with a gentisate compound.
    Type: Application
    Filed: November 1, 2024
    Publication date: April 24, 2025
    Inventors: Joe MCCANN, Mark DORNAN
  • Publication number: 20250057998
    Abstract: A radiopharmaceutical 177Lu-DOTATATE compound, a composition, and a kit are provided. Further provided are methods of synthesis of a 177Lu-DOTATATE compound and methods of treatment that comprise a 177Lu-DOTATATE compound.
    Type: Application
    Filed: August 28, 2024
    Publication date: February 20, 2025
    Inventors: Joe McCANN, Mark DORNAN
  • Patent number: 12195451
    Abstract: Provided are compounds of Formula III that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Grant
    Filed: March 31, 2022
    Date of Patent: January 14, 2025
    Assignee: Ottawa Hospital Research Institute and University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Publication number: 20240360115
    Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Application
    Filed: July 4, 2024
    Publication date: October 31, 2024
    Applicants: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Publication number: 20220220101
    Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Application
    Filed: March 31, 2022
    Publication date: July 14, 2022
    Applicants: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Patent number: 11339146
    Abstract: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: May 24, 2022
    Assignee: Ottawa Hospital Research Institute and University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Publication number: 20200354351
    Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Application
    Filed: May 18, 2020
    Publication date: November 12, 2020
    Applicants: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Patent number: 10654839
    Abstract: Provided are compounds of Formula (II) that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Grant
    Filed: January 26, 2016
    Date of Patent: May 19, 2020
    Assignees: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Publication number: 20180305345
    Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the cytotoxicity of virus to cells. Other uses, compositions and methods of using same are also provided.
    Type: Application
    Filed: January 26, 2016
    Publication date: October 25, 2018
    Applicants: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Fabrice Le Boeuf, John C. Bell, Andrew Macklin, Jeffrey Smith
  • Publication number: 20180112190
    Abstract: Provided are compounds that enhance the efficacy of viruses by increasing spread of the virus in cells, increasing the titer of virus in cells, or increasing the antigen expression from a virus, gene or trans-gene expression from a virus, or virus protein expression in cells. Other uses, compositions and methods of using same are also provided.
    Type: Application
    Filed: January 26, 2016
    Publication date: April 26, 2018
    Applicants: Ottawa Hospital Research Institute, University of Ottawa
    Inventors: Jean-Simon Diallo, Christopher Noyce Boddy, Mark Dornan, Ramya Krishnan, Rozanne Arulanandam, Fabrice Le Boeuf, Jeffrey Smith, Andrew Macklin
  • Publication number: 20100244453
    Abstract: A vertical wind turbine rotatable on its vertical axis in order to capture the most direct vector of the wind, the vertical wind turbine having a horizontal inlet port in communication with a vertical air shaft within which mounted vertically, a shaft having a plurality of horizontally disposed wind turbine blades, the lower end magnetically floating to reduce friction, the lower portion of the vertical wind turbine shaft in intersecting communication with one or more horizontal shafts having a venturi design so as to draw a partial vacuum or low pressure, enhancing the downward flow of the air in the vertical wind turbine, the vertical wind turbine in communication with a generator for the production of electricity, the vertical wind turbine being rotatably but stationary mounted on a stationary object or fixedly mounted on a vehicle with the inlet port of the vertical wind turbine forwardly facing.
    Type: Application
    Filed: March 12, 2010
    Publication date: September 30, 2010
    Inventor: Mark Dornan
  • Patent number: 6568695
    Abstract: An all-terrain riding assembly comprised of a body member, including a supporting surface for feet of the user disposed between a front housing member having a rotatably mounted roller member and a rear housing member having a rotatably mounted, cylindrically-shaped roller member articulatedly mounted to the body member and including an assembly for controlling the rotational velocity of the rear roller member and thus linear velocity of the riding assembly.
    Type: Grant
    Filed: June 29, 2001
    Date of Patent: May 27, 2003
    Inventor: Mark Dornan
  • Publication number: 20030001352
    Abstract: There is disclosed an all-terrain riding assembly comprised of a body member, including a supporting surface for feet of the user disposed between a front housing member having a rotatably mounted roller member and a rear housing member having a rotatably mounted, cylindrically-shaped roller member articulatedly mounted to the body member and including an assembly for controlling the rotational velocity of the rear roller member and thus linear velocity of the riding assembly.
    Type: Application
    Filed: June 29, 2001
    Publication date: January 2, 2003
    Inventor: Mark Dornan
  • Patent number: 6254113
    Abstract: These and other objects of the present invention are achieved by an all-terrain riding assembly comprised of a body member, including a supporting surface for feet of the user disposed between a front housing member having a rotatably mounted roller member and a rear housing member having a rotatably mounted, cylindrically-shaped roller member. A plane defining the supporting surface is below a plane defined by the top portions of the front and rear roller members. In a particular preferred embodiment the rear housing member is articularly mounted to the main body member.
    Type: Grant
    Filed: February 25, 1999
    Date of Patent: July 3, 2001
    Inventor: Mark Dornan
  • Patent number: D273500
    Type: Grant
    Filed: June 11, 1979
    Date of Patent: April 17, 1984
    Inventor: Mark Dornan